Concepedia

Anthony L. Desbien

AL

Statistics

Publications

18

Citations

1.3K

H-Index

17

Active since

2001

Affiliations

Infectious Disease Research Institute(Current)

University of Washington

Aduro BioTech (United States)

PAI Life Sciences (United States)

Genomics Institute of the Novartis Research Foundation

Anthony L. Desbien is an author at Infectious Disease Research Institute specializing in immunology, life sciences, and infectious diseases.

Publications per year

2001–2018

18

Publications

18

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity

Kelsey E. Sivick, Anthony L. Desbien, Laura Hix Glickman et al. · Cell Reports · 2018 · 438 citations · Full text

, , +17

Targeting TLRs Expands the Antibody Repertoire in Response to a Malaria Vaccine

Steven R. Wiley, Vanitha S. Raman, Anthony L. Desbien et al. · Science Translational Medicine · 2011 · 97 citations

, , +16

Recombinant <i>Listeria</i> promotes tumor rejection by CD8 <sup>+</sup> T cell-dependent remodeling of the tumor microenvironment

Weiwen Deng, Victor Lira, Thomas E. Hudson et al. · Proceedings of the National Academy of Sciences · 2018 · 89 citations · Full text

, , +17

The Epstein–Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim

Anthony L. Desbien, John W. Kappler, Philippa Marrack · Proceedings of the National Academy of Sciences · 2009 · 86 citations · Full text

, , +14

TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors

Brian J. Francica, Ali Ghasemzadeh, Anthony L. Desbien et al. · Cancer Immunology Research · 2018 · 85 citations

, , +17

1–5 of 18